Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

NCT: NCT06076499 · ACTIVE_NOT_RECRUITING

NCT IDNCT06076499
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-15
SponsorNoctrix Health, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑